Kui Liao
The Affiliated Yongchuan Hospital of Chongqing Medical University(CN)First Affiliated Hospital of Chongqing Medical University(CN)Chongqing Cancer Hospital(CN)Chongqing Medical University(CN)
Publications by Year
Research Areas
Helicobacter pylori-related gastroenterology studies, RNA Research and Splicing, PARP inhibition in cancer therapy, HIV Research and Treatment, DNA Repair Mechanisms
Most-Cited Works
- → 2-Methoxyestradiol inhibits the proliferation and migration and reduces the radioresistance of nasopharyngeal carcinoma CNE-2 stem cells via NF-κB/HIF-1 signaling pathway inactivation and EMT reversal(2016)60 cited
- Dihydroartemisinin inhibits cell proliferation via AKT/GSK3β/cyclinD1 pathway and induces apoptosis in A549 lung cancer cells.(2014)
- → RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site(2018)28 cited
- → Single-cell sequencing resolves the landscape of immune cells and regulatory mechanisms in HIV-infected immune non-responders(2022)25 cited
- → A comprehensive review of research progress in Chinese medicines for primary liver cancer treatment(2022)22 cited
- → Homologous recombination enhances radioresistance in hypopharyngeal cancer cell line by targeting DNA damage response(2019)20 cited